EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Gene Therapy for Lung Cancer

Humberto Lara-Guerra, Jack A Roth

Critical Reviews™ in Oncogenesis · 2016 · 21 (1-2) · 115-124

DOI: 10.1615/critrevoncog.2016016084 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Critical Reviews™ in Oncogenesis, 2016. Verfasst von Humberto Lara-Guerra und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic and Cardiovascular Surgery, The University of Texas M.D. Anderson Cancer Center, Houston, Texas. Die Arbeit wurde bisher 30-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Gene therapy was originally conceived to treat monogenic diseases. The replacement of a defective gene with a functional gene can theoretically cure the disease. In cancer, multiple genetic defects are present and the molecular profile changes during the course of the disease, making the replacement of all defective genes impossible. To overcome these difficulties, various gene therapy strategies have been adopted, including immune stimulation, transfer of suicide genes, inhibition of driver oncogenes, replacement of tumor-suppressor genes that could mediate apoptosis or anti-angiogenesis, and transfer of genes that enhance conventional treatments such as radiotherapy and chemotherapy. Some of these strategies have been tested successfully in non-small-cell lung cancer patients and the results of laboratory studies and clinical trials are reviewed herein.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AnimalsAntineoplastic Combined Chemotherapy ProtocolsApoptosisCarcinoma, Non-Small-Cell LungClinical Trials as TopicCombined Modality TherapyDrug Evaluation, PreclinicalGene Expression Regulation, NeoplasticGenes, Tumor SuppressorGenetic TherapyHumansLung NeoplasmsMutationRadiotherapyTumor Suppressor Protein p53Tumor Suppressor Proteins

Substanzen

TUSC2 protein, humanTumor Suppressor Protein p53Tumor Suppressor Proteins

Autor:innen und Institutionen

  • Department of Thoracic and Cardiovascular Surgery, The University of Texas M.D. Anderson Cancer Center, Houston, Texas.

Förderung

  • NCI NIH HHS

Zitieren

APA

Lara-Guerra, H., & Roth, J. A. (2016). Gene Therapy for Lung Cancer. Critical Reviews™ in Oncogenesis, 21(1-2), 115-124. https://doi.org/10.1615/critrevoncog.2016016084

Vancouver

Lara-Guerra H, Roth JA. Gene Therapy for Lung Cancer. Critical Reviews™ in Oncogenesis. 2016;21(1-2):115-124. doi:10.1615/critrevoncog.2016016084

BibTeX
@article{LaraGuerra2016,
  author = {Lara-Guerra, Humberto and Roth, Jack A},
  title = {Gene Therapy for Lung Cancer},
  journal = {Critical Reviews™ in Oncogenesis},
  year = {2016},
  volume = {21},
  number = {1-2},
  pages = {115--124},
  doi = {10.1615/critrevoncog.2016016084}
}
Kostenlos starten →